These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 10361120

  • 1. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy.
    Ascherl G, Hohenadl C, Schatz O, Shumay E, Bogner J, Eckhart L, Tschachler E, Monini P, Ensoli B, Stürzl M.
    Blood; 1999 Jun 15; 93(12):4232-41. PubMed ID: 10361120
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.
    Am J Pathol; 1998 Jun 15; 152(6):1433-43. PubMed ID: 9626048
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma.
    Renwick N, Weverling GJ, Brouwer J, Bakker M, Schulz TF, Goudsmit J.
    AIDS Res Hum Retroviruses; 2002 Jul 01; 18(10):695-8. PubMed ID: 12167275
    [Abstract] [Full Text] [Related]

  • 4. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB, Nair BC, Markham P, Nel A, Stürzl M, Ensoli B.
    J Immunol; 1999 Aug 15; 163(4):1929-35. PubMed ID: 10438928
    [Abstract] [Full Text] [Related]

  • 5. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor.
    Weindel K, Marmé D, Weich HA.
    Biochem Biophys Res Commun; 1992 Mar 31; 183(3):1167-74. PubMed ID: 1567395
    [Abstract] [Full Text] [Related]

  • 6. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):267-71. PubMed ID: 10873597
    [Abstract] [Full Text] [Related]

  • 7. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
    Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B.
    J Clin Invest; 1995 Apr 24; 95(4):1723-34. PubMed ID: 7535796
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma.
    Mercié P, Devianne I, Viallard JF, Faure I, Pellegrin I, Leng B, Dupon M, Barbeau P, Fleury H, Pellegrin JL.
    Microvasc Res; 1999 Mar 24; 57(2):208-10. PubMed ID: 10049669
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome.
    Sakurada S, Kato T, Mashiba K, Mori S, Okamoto T.
    Jpn J Cancer Res; 1996 Nov 24; 87(11):1143-52. PubMed ID: 9045943
    [Abstract] [Full Text] [Related]

  • 10. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls.
    Browning PJ, Sechler JM, Kaplan M, Washington RH, Gendelman R, Yarchoan R, Ensoli B, Gallo RC.
    Blood; 1994 Oct 15; 84(8):2711-20. PubMed ID: 7522639
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S, Murakami-Mori K, Rao N, Weich HA, Rajeev B.
    J Immunol; 1997 May 15; 158(10):4992-5001. PubMed ID: 9144519
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, Stürzl M.
    Am J Pathol; 1996 Dec 15; 149(6):1851-69. PubMed ID: 8952523
    [Abstract] [Full Text] [Related]

  • 13. Angiogenic properties of human immunodeficiency virus type 1 Tat protein.
    Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B.
    Proc Natl Acad Sci U S A; 1995 May 23; 92(11):4838-42. PubMed ID: 7539135
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.
    Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS.
    Proc Natl Acad Sci U S A; 1997 Feb 04; 94(3):979-84. PubMed ID: 9023368
    [Abstract] [Full Text] [Related]

  • 15. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
    Bailer RT, Lazo A, Ng-Bautista CL, Hout BL, Ness GM, Hegtvedt AK, Blakeslee JR, Stephens RE, Brierley GP, Mallery SR.
    J Interferon Cytokine Res; 1995 May 04; 15(5):473-83. PubMed ID: 7648450
    [Abstract] [Full Text] [Related]

  • 16. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM.
    J Cell Biochem; 2003 May 01; 89(1):133-43. PubMed ID: 12682914
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
    Samaniego F, Young D, Grimes C, Prospero V, Christofidou-Solomidou M, DeLisser HM, Prakash O, Sahin AA, Wang S.
    Cell Growth Differ; 2002 Aug 01; 13(8):387-95. PubMed ID: 12193477
    [Abstract] [Full Text] [Related]

  • 18. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF, Tognazzi K, Dvorak HF, Harrist TJ.
    Am J Pathol; 1996 Apr 01; 148(4):1065-74. PubMed ID: 8644848
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma.
    Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K, Detmar M.
    J Invest Dermatol; 1999 Dec 01; 113(6):1047-53. PubMed ID: 10594750
    [Abstract] [Full Text] [Related]

  • 20. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.
    Monini P, Colombini S, Stürzl M, Goletti D, Cafaro A, Sgadari C, Buttò S, Franco M, Leone P, Fais S, Leone P, Melucci-Vigo G, Chiozzini C, Carlini F, Ascherl G, Cornali E, Zietz C, Ramazzotti E, Ensoli F, Andreoni M, Pezzotti P, Rezza G, Yarchoan R, Gallo RC, Ensoli B.
    Blood; 1999 Jun 15; 93(12):4044-58. PubMed ID: 10361101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.